Community/Retail

Officials with Novo Nordisk have announced that the FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 16-0, supporting the approval of once-weekly semaglutide to improve glycemic control in adults with type 2 diabetes.

FDA OKs Generic Emend

By

Patients undergoing moderately emetogenic chemotherapy may use the product, in combination with other antiemetic medicines, for the prevention of delayed nausea and vomiting.

The National Community Pharmacists Association (NCPA) Annual Convention, scheduled October 14-18 in Orlando, Florida, will provide plenty of opportunities for community pharmacists to delve into a number of informative and educational sessions.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.